Results

Total Results: 434 records

Showing results for "last months".

401. Evidence Summary: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
     September 28, 2021 - The last surveillance on January 22, 2021, identified no new studies. … follow-up beyond the perinatal period, and it was limited to a subset of the children assessed at age 18 months

402. Screening for Colorectal Cancer: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/n4sdjxShTApRE6UxvyYuzG
     November 01, 2008 - Since the last recommendation in 2002, the mortality reduction previously reported in FUBT trials was

403. 11th Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2021-uspstf-annual-report-to-congress.pdf
     January 01, 2021 - posted 15 final evidence reports For a listing of all final USPSTF recommendations released since the last … THE USPSTF IN 2022 In the coming 12 months, it is expected that the USPSTF will continue to: Develop

404. Archived: High Blood Cholesterol and Other Lipid Abnormalities: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/high-cholesterol-other-lipid-abnormalities-screening-1996
     January 01, 1996 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement High Blood Cholesterol and Other Lipid Abnormalities: Screening, 1996 January 01, 1996 Recommendations made by the USPSTF are in…

405. Final Recommendation Statement: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-medications-for-risk-reduction
     September 03, 2019 - Last, as requested, additional information is provided on selection of medications and menopausal status

406. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review fo the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/k_QR3hvh2jVSPPLu6Q6m6r
     November 13, 2022 - RESULTS Twenty-six studies were included: 22 trials (N = 90 624) with 6 months to 6 years of follow-up … The last surveillance was conducted on May 20, 2022, and identified no studies affecting review conclusions … with reduced risk of clinical outcomes compared with placebo or no statin, based on 22 trials with 6 months

407. Nz Rqwxmmr8Vym-Yjuqru- (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/NZ_RQWxMMR8Vym-yJuqru-
     May 23, 2019 - Harms of screening and treatment Use of valid measurement instrument 57 6 Follow-up for �12 months during

408. Evidence Summary: Prostate Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prostate-cancer-screening
     May 08, 2018 - The last surveillance search was conducted in February 2018; during ongoing surveillance, we identified

409. Archived: Evidence Summary: Diabetes Mellitus (Type 2) in Adults: Screening, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/diabetes-mellitus-type-2-in-adults-screening-2003
     February 03, 2003 - Harms of screening and treatment Use of valid measurement instrument Follow-up for ≥12 months during

410. Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/3HxQuXnyqHpUKNqjB7hWBw
     September 01, 2005 - negative (no mutation found) interpretations but also vari- ants of uncertain clinical significance; this last … in the number of distress indi- cators reported, and follow-up periods ranged from imme- diate to 6 months … aging (MRI), mammography, and ultrasonography, with clinical breast examinations provided every 6 months

411. Screening for Cervical Cancer: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/-6kN7TPcfEj2owG4GTN2jA
     June 01, 2012 - cervical cancer cases are diagnosed in women who have never been screened or have not been screened in the last … positive for HPV compared with those who tested nega- tive; these differences were resolved after 6 months

412. Recommendation: Cervical Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening
     August 21, 2018 - Women who have had CIN 2+ should continue screening for 20 years after the last abnormal test result, … primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months

413. Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia: Evidence Report and Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/9Ks34K-BnsDSBK4MYDATYS
     August 09, 2016 - The last surveillance was conducted on April 9, 2016, and iden- tified no new relevant studies. … During the first 6 months, participants had group visits and indi- vidual family visits, followed by

414. Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/zmvjborz6pkcGVzgcP5nCw
     September 30, 2024 - who had an MRI compared with those receiving only a mammogram were more likely in the subsequent 6 months … Last, in response to comments, the USPSTF added the breast cancer screening recommendations from the

415. Recommendation: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
     April 30, 2024 - who had an MRI compared with those receiving only a mammogram were more likely in the subsequent 6 months … Last, in response to comments, the USPSTF added the breast cancer screening recommendations from the

416. Recommendation: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction
     September 03, 2019 - Last, as requested, additional information is provided on selection of medications and menopausal status

417. 14th Annual Report to Congress: High-Priority Evidence Gaps Across the Lifespan, in All Communities (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2024-11/uspstf-annual-report-congress-2024.pdf
     January 01, 2024 - posted 8 final evidence reports For a listing of all final USPSTF recommendations released since the last … Gaps for Clinical Preventive Services, November 2024 | 26 THE USPSTF IN 2025 In the coming 12 months

418. Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ph_fauqHQjmrSqPAWKrARA
     September 28, 2021 - The last surveillance on January 22, 2021, identified no new studies. … follow-up beyond the perinatal period, and it was limited to a subset of the children assessed at age 18 months

419. Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/_nVeFxDCT9L-_cnDf_V3fK
     July 17, 2018 - The last surveillance was conducted on February 7, 2018, and identified no additional relevant studies … revascularization procedures in patients receiving vs not receiving CAC screening in follow-up of 4 years or 6 months

420. JAMA JATS (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Nvjr8BPsZhy4XGc7-rGjAH
     June 18, 2018 - continue screening for 20 years after the last abnormal test result, even if it extends screening beyond … primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months